| |
| |
|
| Insider
Information: |
Christian Waage |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
652,114 |
|
|
Indirect Shares
|
68,114 |
|
|
| Direct
Value |
$553,545 |
|
|
|
Indirect Value
|
$45,500 |
|
|
| Total
Shares |
720,228 |
|
|
| Total
Value |
$599,045 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
3
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -39.6%
|
-102.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Websense Inc |
WBSN |
VP, General Counsel |
2013-06-25 |
0 |
2013-02-10 |
0 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
SVP & General Counsel |
2015-08-27 |
0 |
2014-09-16 |
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
EVP, Tech Ops and Admin |
2024-03-27 |
585,934 |
2024-03-27 |
68,114 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2024-01-19 |
66,180 |
2019-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GOSS |
Gossamer Bio Inc |
EVP, Tech Ops and Admin |
• – – |
2024-03-27 |
4 |
S |
$1.16 |
$7,430 |
D/D |
(6,430) |
585,934 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2024-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
13,948 |
66,180 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP, Tech Ops and Admin |
• – – |
2023-07-24 |
4 |
A |
$1.82 |
$24,577 |
I/I |
13,504 |
45,892 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP, Tech Ops and Admin |
• – – |
2023-03-20 |
4 |
B |
$1.20 |
$22,145 |
I/I |
18,500 |
32,388 |
1.99 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,580 |
52,232 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP, Tech Ops and Admin |
• – – |
2022-07-15 |
4 |
B |
$7.21 |
$49,994 |
I/I |
6,934 |
13,888 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
EVP, Tech Ops and Admin |
• – – |
2022-03-23 |
4 |
S |
$8.92 |
$95,587 |
D/D |
(10,722) |
579,008 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,452 |
13,652 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-12-21 |
4 |
AS |
$9.73 |
$2,920 |
D/D |
(300) |
3,200 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-09-21 |
4 |
AS |
$12.31 |
$3,692 |
D/D |
(300) |
3,500 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-06-21 |
4 |
AS |
$15.20 |
$4,559 |
D/D |
(300) |
3,800 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-04-15 |
4 |
AS |
$17.51 |
$5,254 |
D/D |
(300) |
4,100 |
0 |
% |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2021-03-23 |
4 |
S |
$9.48 |
$52,051 |
D/D |
(5,490) |
588,199 |
0 |
% |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
593,689 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2020-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
4,400 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2020-10-14 |
4 |
B |
$9.53 |
$23,818 |
I/I |
2,500 |
6,954 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
46,500 |
547,998 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2019-09-27 |
4 |
B |
$16.65 |
$16,654 |
I/I |
1,000 |
4,454 |
1.99 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2019-05-15 |
4 |
B |
$18.04 |
$25,262 |
D/D |
1,400 |
1,400 |
2.39 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2019-02-12 |
4 |
B |
$16.00 |
$24,800 |
D/D |
1,550 |
501,498 |
2.74 |
- |
|
| GOSS |
Gossamer Bio Inc |
EVP & General Counsel |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,454 |
3,454 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
SVP & General Counsel |
• – – |
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,500) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
SVP & General Counsel |
• – – |
2015-05-01 |
4 |
OE |
$22.65 |
$283,125 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
SVP & General Counsel |
• – – |
2015-05-01 |
4 |
AS |
$154.46 |
$1,930,750 |
D/D |
(12,500) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Senior VP & General Counsel |
• – – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
9,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
